Japan PPI inflation slips to 11-mth low in July
HOUSTON—Andrew S. Robinson, Chairman and CEO of Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD), recently sold a significant portion of his holdings in the company. According to a Form 4 filing with the Securities and Exchange Commission, Robinson sold 20,311 shares of common stock on March 6, 2025, at a weighted average price of $50.2399 per share. This transaction totaled approximately $1.02 million. The sale comes amid a notable 11% decline in the stock price over the past week, though the company maintains a strong 35% gain over the past year.
The sale was conducted to cover taxes and fees related to the vesting and settlement of Robinson’s Restricted Stock Units (RSUs). Prior to the sale, Robinson acquired 50,000 shares through the vesting of RSUs granted as part of a 2023 IPO award. As of the transaction date, Robinson holds 82,044 shares of Skyward Specialty Insurance Group. The transaction occurs as the company demonstrates solid financial performance, with a healthy current ratio of 1.96 and strong profitability metrics.
Skyward Specialty Insurance Group, headquartered in Houston, operates in the fire, marine, and casualty insurance sector. The company’s recent activities reflect ongoing executive compensation adjustments and strategic financial management. According to InvestingPro analysis, Skyward maintains a "GREAT" financial health score, with analysts projecting continued profitability for the year ahead. For deeper insights into SKWD’s valuation and growth prospects, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Skyward Specialty Insurance Group reported strong fourth-quarter 2024 earnings, with an earnings per share (EPS) of $0.8, exceeding the forecast of $0.65. The company’s revenue also surpassed expectations, reaching $304.4 million against a projected $265.04 million. Keefe, Bruyette & Woods (KBW) responded to these robust results by raising their price target for Skyward Specialty to $62.00, up from $60.00, while maintaining an Outperform rating. In contrast, Wolfe Research downgraded the stock from Outperform to Peer Perform, citing concerns over trading multiples and risk-return profile. Wolfe Research has set a year-end 2025 fair value range for the company between $50 to $59. Jefferies also adjusted their price target to $62.00 and reaffirmed a Buy rating, noting the company’s strong quarterly performance and steady 2025 guidance. Skyward Specialty’s gross written premiums grew by 21% in the fourth quarter, contributing to a full-year growth of 19%. The company continues to explore potential mergers and acquisitions while maintaining conservative risk and capital management strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.